Success Story: Biomedical Innovation and Cancer Research Lead to NIW Approval for a Bangladeshi Scientist
Client’s Testimonial:
"I was also truly pleased to work with your team, as you are such an experienced and professional law firm. I sincerely appreciate all of your hard work and effort on my case. Thank you so much for your dedication to helping me achieve success in this step of the process.”
On May 12th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Associate in the Field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: Bangladesh
State of Residence at the Time of Filing: Washington
Approval Notice Date: May 12th, 2026
Processing Time: 18 months, 4 days (Premium Processing Requested)
Case Summary:
A postdoctoral research associate from Bangladesh sought legal assistance from North America Immigration Law Group (Chen Immigration Law Associates) for an NIW petition based on his work in biomedical science. The client had built a strong research record spanning molecular biology, immunology, drug development, and disease-focused biomedical research.
The petition centered on the client’s proposed endeavor to develop advanced therapeutic strategies aimed at improving severe disease prevention and treatment. Our team framed the work around a broader public health need: advancing critical medical research, expanding therapeutic options, reducing overarching healthcare costs, and strengthening U.S. leadership in biomedical innovation.
The client’s credentials provided strong support for this framing. His research has resulted in 32 peer-reviewed journal articles and 1 granted patent. His work had also received 660 citations, reflecting substantial reliance by other researchers in biomedical science. Several of his papers ranked among the top 10% and top 20% most-cited Immunology articles for their publication years.
The petition also highlighted his record of service, including at least two completed reviews for authoritative journals in the field. He also documented prior research funding from entities such as the Ministry of Science and Technology of Bangladesh and the University Grants Commission of Bangladesh. Together, these materials showed that the client was well-positioned to continue advancing research with meaningful implications for public health and cancer treatment.
After a Premium Processing upgrade was submitted on March 13, 2026, USCIS approved this I-140 NIW petition on May 12, 2026. This outcome reflects NAILG’s careful presentation of a petition that connected the client’s biomedical research background, publication record, citation impact, and future research plans to broader U.S. interests in cancer treatment, biotechnology, and public health.

